News Industry News NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR) August 30, 2017
News Industry News 4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec July 20, 2017
News Industry News 4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum June 08, 2017
News Industry News NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation April 26, 2017